Duke-NUS researchers Professor Karl Tryggvason, Professor David M. Virshup and Professor Antonio Bertoletti were awarded...
The Health Sciences Authority (HSA) in Singapore has recalled three brands of high blood pressure medicine which contain...
Accuron MedTech Group, Southeast Asia's largest medical device business, has announced the change of its corporate name ...
Held at One Farrer Hotel Singapore, the event brought together more than 150 speakers and delegates from both private an...
Researchers from Duke-NUS Medical School, Singapore General Hospital (SGH) and Lion TCR have demonstrated that they were...
Farrer Park Hospital (FPH), Singapore's newest private healthcare service provider, successfully implanted the world's s...
Researchers at Duke-NUS Medical School, Singapore, have developed an approach to regenerate heart muscle using stem cell...
Hyphens is currently licensing sugar-based surfactant micro-emulsions technology from A*STAR’s Institute of Chemic...
Scientists from National University of Singapore (NUS) have taken inspiration from underwater invertebrates like jellyfi...
On 18- 20 March 2019 after a successful 2018 debut, Phar-East once again brought together experts from Asian pharma &...
Headquartered in Singapore, healthcare communications firm, SPAG (A Strategic Partners Group enterprise), has appointed ...
ConnectedLife and Ocean Protocol announce their partnership to advance Parkinson's Disease (PD) diagnosis and treatment ...
Three finalists in Singapore were announced today in the Alipay-NUS Enterprise Social Innovation Challenge (“Chall...
CXA Group, Asia's one-stop, predictive and data intelligence platform for better health, wealth and wellness choices, ha...
Singaporeans are among the world’s worst sleepers, getting just 6.3 hours of sleep on the weekdays and 6.7 on the ...
Lucence Diagnostics, a genomic medicine company focused on personalizing cancer care, has announced a new project to dev...
ASLAN Pharmaceuticals, a clinical-stage oncology-focused biopharmaceutical company developing novel therapeutics for glo...
Advent Access (Advent), one of Singapore’s most innovative medtech companies, has announced that it has been selec...
